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Abstract
Background: Continuous exposure to many chemicals, including through air, water, food, or other media and
products results in health impacts which have been well assessed, however little is known about the total disease
burden related to chemicals. This is important to know for overall policy actions and priorities. In this article the
known burden related to selected chemicals or their mixtures, main data gaps, and the link to public health policy
are reviewed.
Methods: A systematic review of the literature for global burden of disease estimates from chemicals was
conducted. Global disease due to chemicals was estimated using standard methodology of the Global Burden of
Disease.
Results: In total, 4.9 million deaths (8.3% of total) and 86 million Disability-Adjusted Life Years (DALYs) (5.7% of
total) were attributable to environmental exposure and management of selected chemicals in 2004. The largest
contributors include indoor smoke from solid fuel use, outdoor air pollution and second-hand smoke, with 2.0,
1.2 and 0.6 million deaths annually. These are followed by occupational particulates, chemicals involved in acute
poisonings, and pesticides involved in self-poisonings, with 375,000, 240,000 and 186,000 annual deaths,
respectively.
Conclusions: The known burden due to chemicals is considerable. This information supports decision-making in
programmes having a role to play in reducing human exposure to toxic chemicals. These figures present only a
number of chemicals for which data are available, therefore, they are more likely an underestimate of the actual
burden. Chemicals with known health effects, such as dioxins, cadmium, mercury or chronic exposure to pesticides
could not be included in this article due to incomplete data and information. Effective public health interventions
are known to manage chemicals and limit their public health impacts and should be implemented at national and
international levels.
Background
Chemicals are part of our daily lives. On the other hand,
they may cause diseases. Which fraction of the current
disease burden do chemicals however cause, and which
are the chemicals of greatest concern? This is an impor-
tant question for decision-makers in order to prioritize
efforts to protect us from the harmful effects of
chemicals.
This article describes and summarizes the main esti-
mates available to date of the health impact of chemicals
on the population at global level. It provides their sum
and the relative importance of the groups of chemicals
contributing to these health impacts. This information
on the collective role of chemicals as contributors to
global disease may assist policy makers in setting priori-
ties in view of health protection. As the population
health impacts from many chemicals have not yet been
assessed, an overview of exposures and health impacts is
provided to map estimated disease burden to the actual
burden and identify data gaps. We also outline the main
exposures involved and highlight areas relevant to pre-
vention of exposure.
This review has focused on toxic exposures to chemi-
cals which can be significantly reduced or eliminated
through environmental and occupational management.
These environmental exposures to chemicals cause a
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been attracting considerable attention of the public, pol-
icy makers and research communities. This situation has
been the main motivation for undertaking this review,
and for defining its focus. Chemical exposures that are
not primarily linked to environmental management, as
for example active smoking, are not addressed in this
review. Radioactive substances have equally not been
included here, as they have a different mechanism of
action, often concern other interest groups and require
a specific set of safety measures. Indirect consequences
of chemicals, acting for example through climate
change, have not been taken into account.
Human exposure to chemicals
Chemicals, whether of natural origin or produced by
human activities, are part of our environment. Naturally
occurring chemicals include arsenic and fluoride in drink-
ing water, suspended particulate matter and sulfur dioxide
from volcanic emission or forest fires, or naturally occur-
ring toxins. Manufactured chemicals include industrial
and agricultural products such as pesticides, petroleum
products, processed metals, and products of combustion
such as toxic gases and particles from industrial emissions
and burning of fuel. Some chemicals are manufactured for
specific uses, while others are unwanted by-products,
wastes, or products of combustion.
Their chemical, physical and toxicological properties
vary greatly - while many are not hazardous or persis-
tent, some are life-threatening on contact and some per-
sist in the environment, accumulate in the food chain,
travel large distances from where they are released, and
are harmful to human health in small amounts. Human
exposure can occur at different stages of the life-cycle of
a chemical, including through occupational exposure
during manufacture, use and disposal, consumer expo-
sure, exposure to contaminated products, or environ-
mental exposure to toxic waste (Figure 1). Exposure can
occur via various pathways, including inhalation of con-
taminated air and dust, ingestion of contaminated water
and food, dermal exposure to chemical or contaminated
products, or fetal exposure during pregnancy (Table 1).
Further information on human exposure to chemicals is
available from a variety of documents [1-4]. As illu-
strated in Figure 1, several sectors and programmes
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Figure 1 Human exposure to chemicals throughout their life-cycle and selected programmes relevant to their prevention.
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throughout their life cycle, including health, environ-
ment, agriculture, energy and transport sectors, and
water, food and chemical safety programmes.
Methods
We systematically reviewed the published literature for
studies estimating the disease burden, expressed in
deaths or DALYs (a measure combining mortality and
morbidity), either at global level or covering a large part
of the total burden (i.e. national level estimates were
generally not retained). We reviewed the disease burden
estimates developed by the World Health Organization
and those published in the peer reviewed literature. We
used combinations of the terms of main chemicals of
concern or their mixtures (which might be expected to
have broad exposure information and epidemiological
evidence, see Additional file 1: Search terms used in
Pubmed), “global”, “world health”, “burden”, “impacts”,
“effects” and “review” in PubMed Databases and Google
from 1990 to December 2009.
Relevant estimates were found for 14 chemicals or their
groups or mixtures. Most estimates were developed by
groups of experts coordinated by the World Health Orga-
nization. Methods underlying the estimates were reviewed
and summarized. For estimating the total known burden of
disease from chemicals, methods were reviewed for
compatibility, summed up and categorized into broad
exposure groups. Estimates from overlapping exposures
(i.e. compounds appearing again in mixtures) were removed.
In order to map the available estimates of disease bur-
den to the total burden of disease from chemicals we
reviewed the literature to develop a basic frame. Table 2
lists the main health outcomes associated with exposure
to toxic chemicals to illustrate this wide range of diseases.
Methods underlying the burden of disease estimates
In most disease burden estimates for risk factors, the
basic method can be summarized in the following steps:
(a) estimating the exposure distribution in a population;
( b )s e l e c t i n go n eo rm o r ea p p r o p r i a t er e l a t i v er i s ke s t i -
mates from the literature, generally from a recent meta-
analysis; and (c) estimating the population attributable
fraction (simplified formula in Panel 1 [5,6]). The result-
ing population attributable fractions, estimated for each
disease, age group, gender, and population group, are
then multiplied by the total number of deaths and dis-
ability-adjusted life years (DALYs) for the disease in
each population group. DALYs are a weighted measure
of deaths and disability [7].
Panel 1: Population attributable fraction
PAF
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Table 1 Examples of sources and pathways of human exposure to a few selected chemicals
Exposure
media
Example sources of exposure and exposure pathways Examples of chemicals
Outdoor air Inhalation of toxic gases and particles from vehicle and industrial
emissions, or naturally occurring sources such as volcanic
emission or forest fires.
Sulfur dioxide, nitrogen oxides, ozone, suspended particulate
matter, lead, benzene, dioxins and dioxins-like compounds
Indoor air Inhalation of pollutants released during indoor combustion of
solid fuels, tobacco smoking, or from construction materials and
furnishings, contaminants in indoor air and dust.
Suspended particulate matter, nitrous oxide, sulfur oxides, carbon
monoxide, formaldehyde, polyaromatic hydrocarbons (PAH),
mercury, lead dust from lead-based paints, benzene, asbestos,
mycotoxins, phtalates, polybrominated diphenyl ether fire
retardants (PBDEs)
Drinking
water
Ingestion of drinking water contaminated with toxic chemicals
from industrial effluents, human dwellings, agricultural runoff, oil
and mining wastes, or from natural sources.
Pesticides, herbicides, fertilisers, metals (copper, lead, mercury,
selenium, chromium), arsenic, fluoride, nitrate, cyanide, industrial
solvents, petroleum products, disinfection by-products.
Food Consumption of food contaminated with chemicals at toxic levels
through agricultural practices, industrial processes, environmental
contamination, and natural toxins.
Pesticides, methylmercury, lead, cadmium, dioxins, aflatoxin.
Non-food
consumer
products
Exposure by ingestion, inhalation or dermal exposure to toxic
chemicals contained in toys, jewellery and decoration items,
textiles, or food containers, consumer chemical products
Lead, mercury, cadmium, phthalates, formaldehyde, dyes,
fungicides or pesticides.
Soil Ingestion (particularly for children) or inhalation of soil
contaminated through industrial processes, agricultural processes
or inadequate household and industrial waste management.
heavy metals, pesticides, and persistent organic pollutants.
Occupational
exposure
Chronic or acute exposures through inhalation, dermal
absorption, or secondary ingestion of toxic chemicals or by-
products of industrial processes such as agriculture, mining or
manufacturing.
Pesticides, benzene, heavy metals, solvents, suspended
particulate matter.
Human to
human
Foetal exposure to toxic chemicals during pregnancy (through
placental barrier) or through consumption of contaminated breast
milk.
Heavy metals, pesticides, benzene, etc.
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The available disease burden estimates have been
developed with variations of the above method, or dif-
ferent approaches supported by differing levels of evi-
dence. Additional features on the various approaches
used are detailed as follows:
Comparative Risk Assessment (CRA)
The method systematically assesses changes in popula-
tion health by varying distribution of exposure using a
unified framework linked to the Global Burden of Dis-
ease [7]; Developed by WHO and numerous experts, [8]
this study included risk factors causing more than 0.5%
of the global disease burden, with high likelihood of
causality, and reasonably complete exposure data.
CRA approaches involve estimating the disease burden
compared to a “counterfactual” exposure distribution
which will generally lead to the lowest conceivable dis-
ease burden, irrespective of whether currently attainable
in practice [9]. For example, the counterfactual exposure
for outdoor air pollution was the natural background
level of particulate matter, and zero for second-hand
smoke. The disease burden estimates essentially repre-
sent the burden that could be prevented if the risk fac-
tors were removed. Additional details of the methods
are provided in greater detail in the original publications
[8-10].
Limitations of the CRA approach include (a) the lim-
ited scope by addressing only risk factors with large
Table 2 Main disease groups with suspected or confirmed linkage to chemicals
Diseases/disease
groups
Examples of exposures Examples of associated outcomes [22,66,67]
Respiratory infections
and chronic respiratory
diseases
Occupational exposures to dusts, gases, irritant chemicals, fumes Chronic Obstructive Pulmonary Disease (COPD)
[68,69]
Second-hand smoke; occupational exposures to cleaning-agents,
pesticides, hairdressing chemicals etc.
Asthma onset and exacerbation [28,70-72]
Second-hand smoke Acute lower respiratory infections [28]
Occupational exposure to asbestos Metal dusts, particulate matter Asbestosis Bronchitis, pneumoconiosis, silicosis
Perinatal conditions Maternal exposure to pesticides or other chemicals Low-birth-weight and preterm infants [73-76]
Congenital anomalies Maternal exposure to pesticides, polychlorinated biphenyls (PCBs),
polychlorinated dibenzofurans (PCDFs), lead, mercury, other
endocrine disruptors
Various birth defects [77,78]
Diseases of the blood Lead, arsine, naphthalene, benzene Anaemia, methaemoglobinemia
Cancers Occupational exposures to carcinogens, aflatoxins in food, second-
hand smoke, outdoor air pollution by carbon particles associated
with polycyclic aromatic hydrocarbons, asbestos, arsenic; volatile
organic compounds such as benzene, pesticides, dioxins. etc.
Numerous cancer sites, including of the lung, skin,
liver, brain, kidney, prostate, bone marrow, bladder
[79-82]
Neuropsychiatric and
developmental
disorders
Lead, methylmercury, polychlorinated biphenyls (PCBs), arsenic,
toluene etc.
Cognitive development, mental retardation, Parkinson
disease, Attention-deficit disorder, Minamata disease
[51,78,83,84]
Sense organ diseases Carbon disulfide, mercury, lead Hearing loss
Cardiovascular diseases Ultrafine particles in polluted air, lead, arsenic, cadmium, mercury,
pollutant gases, solvents, pesticides, second-hand smoke
Ischaemic heart disease, cerebrovascular disease
[28,49,85]
Diabetes mellitus Arsenic, N-3-pyridylmethyl-N’-p-nitrophenyl urea (rodenticide),
2,3,7,8-Tetrachlorodibenzo-p-dioxin.
Diabetes Type II [86-89]
Systemic auto immune
diseases
Crystaline silica dust Systemic sclerosis, systemic lupus erythematosus,
rheumatoid arthritis, systemic small vessel vasculitis
[90]
Endocrine diseases Ethanol, hexachlorobenzene Porphyria
Genito-urinary diseases Beryllium, cadmium, lead Calculus of kidney, chronic renal disease
Digestive diseases Ethanol, chloroform, carbon tetrachloride, manganese Hepatitis, cholestasis, pancreatitis
Skin diseases Antiseptics, aromatic amines, cement, dyes, formaldehyde, artificial
fertilizers, cutting oils, fragrances, glues, lanolins, latex, metals,
pesticides, potassium dichromate, preservatives
Atopic dermatitis, allergic and irritant contact
dermatitis, chloracne, hyperkeratosis [91]
Musculoskeletal diseases Cadmium, lead Osteoporosis, gout
Oral conditions Fluoride Dental fluorosis
Poisonings Accidental ingestion of household products, occupational
exposures and accidents, intentional self-harm by ingestion of
pesticides
Unintentional poisonings, self-inflicted injuries [92-94]
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evidence, not taking account of “likely” impacts (which
can also be seen as an advantage) and therefore gener-
ally underestimating the total impacts; (c) the inclusion
of only those diseases defined through the International
Classification of Diseases (ICD), rather than all health
effects. For example loss of IQ points from lead (unless
resulting in mental retardation) has not been taken into
account, as it is not a disease according to ICD.
Other exposure-based estimates than CRA
Some estimates use methods similar to the CRA but not
necessarily a unified framework [11,12]. This means that
the choice of outcomes and exposure-risk relationships
does not necessarily underlie specific selection criteria,
and that different approaches are used in terms of coun-
terfactual scenarios (i.e. alternative exposure scenario).
Such assessments may be equally rigorous as compared
to the CRA, but results may not be comparable or addi-
tive with CRA estimates.
Estimates based on evidence synthesis completed with
expert opinion
These methods combine CRA estimates and evidence
synthesis from partial or geographically limited assess-
ments, and fill knowledge gaps with expert estimates.
This approach may provide approximate estimates when
global exposure information is limited, or when quanti-
tative exposure-risk relationships are supported by
weaker evidence. Rigorous estimates can so be com-
pleted to obtain a fuller picture of likely population
health impacts from various risks. The main disadvan-
tage obviously consists in the lower level of evidence
supporting those estimates. Further details on the
method are provided in the original publication [13].
Before adding up the estimated burden of disease from
various chemicals, any joint effects of different risks need
to be considered. The burden of disease estimates describe
the burden that would be removed if exposure was
reduced to the counterfactual exposure [8]. As diseases
may be caused by multiple factors, the estimated disease
burdens could add up to more than 100%. For example,
one childhood deaths of respiratory infection of an under-
weight child could be prevented both by removing the
source of indoor air pollution, or by improved nutrition
[8]. Deaths from those two risk factors should therefore
not be added up. In the case of the chemicals identified in
this article, however, significant overestimation of the bur-
den due to joint effects is unlikely: few exposures are
expected to overlap significantly and at the same time
cause synergistic effects or health impacts that could be
avoided by reducing either of those exposures. For greater
consistency with previous estimates and better compar-
ability and additivity, we preferred CRA types of assess-
ments and others using a counterfactual exposure.
Results
The systematic literature review revealed burden of disease
estimates for the following chemicals or groups of chemi-
cals: (a) chemicals involved in unintentional acute poison-
ings, (b) chemicals involved in unintentional occupational
poisonings, (c) pesticides involved in self-inflicted injuries,
(d) asbestos, (e) occupational lung carcinogens, (f) occupa-
tional leukaemogens, (g) occupational particulates, (h) out-
door air pollutants, (i) indoor air pollutants from solid fuel
combustion, (j) second-hand smoke, (k) lead, and (l)
arsenic in drinking water. The following paragraphs
describe and discuss available estimates for these chemi-
cals. An overview of the global burden of disease attributa-
ble to these chemicals is presented in Table 3. More
detailed descriptions of the methods used for the pre-
sented burden of disease estimates are found in the origi-
nal referenced publications. Most of the identified burden
of disease estimates from chemicals follow CRA methods
and provide data for the year 2004 [14], which was used as
the reference year in this article.
Chemicals in unintentional acute poisonings
Unintentional ingestion, inhalation or contact with che-
micals caused 346,000 deaths (7,447,000 DALYs) from
acute poisonings in 2004. About 71% of unintentional
poisonings were estimated to be preventable through
improved chemical safety [13], amounting to 240,000
deaths and 5,246,000 DALYs in 2004. The share of this
disease burden affecting children amounts to 19%, and
30,000 deaths were estimated to occur at the workplace.
Chemicals responsible for unintentional poisonings may
include methanol, diethylene glycol, kerosene, pesticides,
and many others. Original methods for occupational poi-
sonings were developed in the CRA framework [15]. This
estimate also includes inadequate use of pharmaceuticals,
which is however likely to be a minor contributor.
Pesticides in self-inflicted injuries
A large body of evidence supports the causation of var-
ious diseases (e.g. cancers, birth defects) and other
health effects (e.g. endocrine disruption, neurotoxicity,
kidney/liver damage) by exposure to pesticides [16].
Both exposure and exposure-response data available are
unfortunately too limited to estimate the global health
impacts of pesticides. The global impact of self-poison-
ing (suicides attempts) from preventable pesticide inges-
tion was, however, estimated to amount to 186,000
deaths and 4,420,000 DALYs in 2002 (analysis of evi-
dence complemented by expert opinion [13]). The total
burden of suicides from pesticide ingestion was esti-
mated to amount to 258,000 deaths in 2002 with a
more rigorous approach, but the former estimate is used
in this context for methodological reasons (includes a
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Chemicals/Groups of chemicals Disease outcomes considered
(attributable fraction)
Deaths DALYs
‡ Main limitations¤ Data
year/
method
§
Chemicals in acute poisonings 526,000
(sub-total)
9,666,000
(sub-total)
Chemicals (including drugs) involved in unintentional acute
poisonings (methanol, diethylene glycol, kerosene, pesticides
etc.)
Unintentional poisonings (71%) 240,000
a 5,246,000
a Limited to preventable poisonings. Total
unintentional poisonings would amount to
346,000 deaths and 7,445,000 DALYs[12]
2004; C
[13]
b
Chemicals involved in unintentional occupational poisonings Unintentional poisonings (occupational)
(8.6%)
30,000
c 643,000
c - 2004; A
[14]
Pesticides pesticides involved in self-inflicted injuries Self-inflicted injuries (23%) 186,000 4,420,000 Limited to preventable self inflicted injuries.
Impact of accidental and chronic exposures not
considered.
2002; C
[13]
Chemicals in occupational exposures (longer term effects) 581,000
(sub-total)
6,763,000
(sub-total)
Asbestos Malignant mesothelioma (NA); trachea,
bronchus, lung cancer (0.3%); asbestosis (NA)
107,000
d 1,523,000
d - 2004; A
[14]
, [50]
Occupational lung carcinogens (arsenic, asbestos, beryllium,
cadmium, chromium, diesel exhaust, nickel, silica)
Trachea, bronchus, lung cancer (8.6%) 111,000 1,011,000 Only 8 of the chemicals or chemical mixtures
classified as carcinogenic or probably carcinogenic
to humans taken into account
2004; A
[14]
Occupational leukaemogens (benzene, ethylene oxide, ionizing
radiation)
Leukaemia (2.3%) 7,400
e 113,000
e Only 2 of the chemicals or chemical mixtures
classified as carcinogenic or probably carcinogenic
to humans taken into account
2004; A
[14]
Occupational particulates - causing COPD (dusts, fumes/gas) COPD (13%) 375,000
f 3,804,000
f - 2004; A
[14]
Occupational particulates - other respiratory diseases than
COPD (silica, asbestos and coal mine dust)
Asbestosis (NA); silicosis (NA);
pneumoconiosis (NA)
29,000 1,062,000 - 2004; A
[14]
Air pollutant mixtures 3,720,000
(sub-total)
60,669,000
(sub-total)
Outdoor air pollutants (particulate matter, sulfur dioxide,
nitrogen oxides, benzo[a]pyrene, benzene, others)
Lung cancer (7.9%); acute respiratory
infections (1.6%); selected cardiopulmonary
diseases (3.4%)
1,152,000 8,747,000 Only urban air pollution in cities with >100 000
inhabitants taken into account. Health impact
from rural air pollution unknown.
2004; A
[14]
Outdoor air pollutants emitted from ships (particulate matter,
sulfur dioxide, nitrogen oxides, benzo[a]pyrene, benzene,
others)
Lung cancer (0.3%); selected
cardiopulmonary diseases (0.4%)
60,000
g NA - 2002; B
[95]
Indoor air pollutants from solid fuel combustion (carbon
monoxide, nitrogen oxides, sulfur oxides, benzene,
formaldehyde, polyaromatic compounds, particulates, others)
Lung cancer (2.9%); acute respiratory
infections (33%); COPD (33%)
1,965,000 41,009,000 Disease burden from emissions from building
materials and household products is not know.
BoD from second hand smoke has been
evaluated separately.
2004; A
[14]
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5Table 3 Overview of available disease burden estimates attributable to chemicals (Continued)
Second-hand smoke (nicotine, formaldehyde, carbon
monoxide, phenols, nitrogen oxides, naphthalenes, tar,
nitrosamine, PAHs, vinyl chloride, various metals, hydrogen
cyanide, ammonia, others)
Lower respiratory infections (6.3%); otitis
(1.7%); asthma (11%); lung cancer (1.8%);
ischaemic heart disease (4.5%)
603,000 10,913,000 - 2004; B
[29]
Single chemicals with mostly longer term effects 152,000
(sub-total)
9,102,000
(sub-total)
Lead Mild mental retardation; Cardiovascular
diseases
143,000 8,977,000 - 2004; A
[14]
Arsenic in drinking-water Diabetes mellitus (0.04%) ischemic heart
disease (0,11%); lung cancer (0.25%); bladder
cancer (1.2%); kidney cancer (NA); skin
cancer (0.30%)
9,100
a 125,000
a Limited to exposure through drinking water.
Limited to Bangladesh.
2001; B
[11]
Total
#,h Total in children <15 years All considered diseases 4,879,000
(8.3%)
1,073,000
(22%)
86,200,000
(5.7%)
46,627,000
(54%)
Mainly
2004; A
‡ DALYs are “Disability-adjusted life years”, a weighted measure of years of life lost due to premature death, and years lived with disability. ¤ Only outcomes qualified as strong evidence were considered.
§ Methods:
A: Comparative Risk Assessment (CRA); B: Based on exposure and exposure-response (similar to CRA); C: Evidence synthesis and expert evaluation.
# The estimates were developed within three years and their
pooling is unlikely to introduce a significant error. NA: not available. -: none.
a Estimate not compared to counterfactual exposure, which is however estimated to be negligible using a theoretical minimum exposure given available management options for concerned chemicals.
b Values updated for 2004 based on original reference.
c Already included in total unintentional acute poisonings and therefore not included again in the total.
d Lung cancer and asbestosis caused by asbestos are also considered in occupational lung carcinogens and particulates and this part of the burden is therefore not counted twice in the total.
e Also includes a small fraction of leukaemia caused by ionizing radiation.
f Parts of the particulates are organic in nature, and the estimate therefore includes a small fraction that is not or not directly related to chemicals.
g Overlaps with the burden from outdoor air pollution and is therefore not included in the total.
h Total is corrected for double counting (chemicals considered in more than one estimate); not all disease burdens are however additive, and joint exposures could lead to slight overestimate (see Methods section).
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5counterfactual approach, to allow for additivity of
results) [12]. Current evidence supports that suicide
rates could be significantly reduced through limiting
access to lethal means, among other methods [17,18].
About 30% of self-inflicted injuries globally involve pes-
ticides, and occur mainly in Asia and to a lesser extent
in almost all other parts of the world.
Asbestos
Exposure to asbestos causes lung cancer, mesothelioma
and asbestosis (fibrosis of the lungs), and other out-
comes [19]. The global burden of disease attributable to
asbestos has been estimated to amount to 107,000
deaths and 1,523,000 DALYs for the three mentioned
diseases in 2004. Among these, 41,000 deaths and
370,000 DALYs were due to asbestos-caused lung can-
cer, and 7,000 deaths and 380,000 DALYs to asbestosis.
The remaining 59,000 deaths and 773,000 DALYs were
attributed to malignant mesothelioma [14,15,20]. Deaths
and DALYs from lung cancer and asbestosis are also
included in the estimates for occupational lung carcino-
gens and occupational particulates, and are therefore
not counted twice when summing the total disease
burden from chemicals in Table 3.
Occupational lung carcinogens
Occupational exposure to arsenic, asbestos, beryllium,
cadmium, chromium, diesel exhaust, nickel and silica
were estimated to cause 111,000 deaths (and 1,011,000
DALYs) from lung cancer in 2004 [14]. This represents
about 9% of the total burden of lung cancer. Health
impacts from additional lung carcinogens, such as bis
(chloromethyl)ether, 2,3,7,8-TCDD, soot exposure while
chimney sweeping, aluminium production, iron and
steel founding, rubber manufacturing among others
could not be estimated [21].
Occupational leukaemogens
Benzene, ethylene oxide and ionizing radiation were the
only occupational leukaemogens considered in the esti-
mation of global burden of disease from occupational
leukaemogens [15]. This analysis resulted in a total of
7,400 deaths (and 113,000 DALYs) in 2004 [14], repre-
senting 2.3% of the total burden of leukaemia. IARC has
classified few additional chemicals or exposures as sup-
ported by sufficient evidence in their association with
leukaemia, including formaldehyde and exposures in the
rubber manufacturing industry [21].
Occupational particulates
Exposure to particulate matter has been linked to a vast
range of respiratory and other diseases. The estimation
of disease burden from occupational exposure to parti-
culate matter was limited to selected respiratory diseases
as exposure and risk information at global level is
l i m i t e d[ 1 5 ] .E f f e c t sf r o me x p o s u r et od u s ta n d / o rg a s /
fumes on COPD, and from exposure to silica, asbestos
and coal mine dust on silicosis, asbestosis and coal
workers’ pneumoconiosis were considered. The esti-
mated health impacts were 375,000 deaths and
3,804,000 DALYs from COPD, and 29,000 deaths and
1,061,000 DALYs from asbestosis, silicosis and pneumo-
coniosis in 2004 [14,20]. Occupational agents associated
with the development of COPD include for example
mineral fumes, welding fumes, cadmium fumes and sul-
fur dioxide [22]. The fraction of COPD attributable to
occupational particulates is estimated to amount to 13%
globally. Some dusts of biological nature, such as cotton,
grain and wood dusts, are also suspected to have a role
in COPD causation [22]. Despite the possible inclusion
of biological dusts, this estimate may still be an underes-
timate as only part of the respiratory diseases caused by
chemicals were considered.
Outdoor air pollutants
Outdoor air pollution contains particulate matter and
gaseous pollutants, such as sulfur dioxide (SO2), nitro-
gen oxides (NOx) and carbon monoxide (CO), as well as
secondary pollutants such as ozone (O3)f o r m e df r o m
directly emitted pollutants. Further constituents of the
pollutant mixture include carcinogens such as benzo[a]
pyrene, benzene and 1,3-butadiene [23]. Health impacts
from urban air pollution, largely from combustion
sources, caused overall about 1,152,000 deaths
(8,747,000 DALYs) worldwide in 2004 [14,24]. In parti-
cular, respiratory infections in children contributed
121,000 deaths (1,555,000 DALYs) to this burden, lung
cancer 108,000 deaths (931,000 DALYs) and other cardi-
opulmonary illnesses 923,000 deaths (6,261,000 DALYs).
About 10% of this burden is estimated to affect children.
Exposure was measured, and modeled when not avail-
able, using particulate matter (PM10 and PM2.5)a sa n
index for common mixtures of urban air pollution [24].
These estimates cover cities with >100,000 inhabitants.
Rural outdoor air pollution, e.g. caused by forest fires
[25] or indoor combustion of solid fuels, may also con-
tribute to global health impacts and have not been
estimated.
Indoor air pollutants from solid fuel combustion
Indoor air pollution is caused by both traditional
sources of pollution, primarily by the combustion of
solid fuels for cooking or heating, and modern sources
such as building materials and household products emit-
ting chemicals. Household combustion of coal or bio-
mass produces smoke that contains carbon monoxide
(CO), nitrogen oxides (NOx), sulfur oxides (SOx), ben-
zene, formaldehyde, polyaromatic compounds, and
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household products can release toxic chemicals such as
benzene and formaldehyde. About half of the world’s
households still use solid fuels, which were estimated to
cause 872,000 deaths (30,854,000 DALYs) from lower
respiratory infections in children, 36,000 deaths (338,000
DALYs) from lung cancer, and 1,057,000 deaths
(9,817,000 DALYs) from COPD in 2004 [14]. With 75%,
children bear the greatest burden from exposure to
these pollutants. This estimate only covered indoor
smoke from solid fuel combustion, and did not address
emissions from building materials and household pro-
ducts, such as benzene and formaldehyde, and other
indoor air contaminants.
Second-hand smoke
Second-hand smoke is a complex mixture of com-
pounds emanating from tobacco smoke causing indoor
air pollution. These include more than 30 known or sus-
pected human carcinogens, such as 4-aminobiphenyl,
2-aminonaphthalene, benzene, nickel, and a variety of
polycyclic aromatic hydrocarbons (PAHs) and N-nitrosa-
mines [27]. A number of irritants, such as ammonia,
nitrogen oxides, sulfur dioxide and various aldehydes,
and cardiovascular toxicants, such as carbon monoxide,
nicotine and some PAHs, are also present [28]. Second-
hand smoke was estimated to cause 166,000 deaths
(6,616,000 DALYs) in children in 2004, and 436,000
deaths (4,297,000 DALYs) in non-smoking adults [29],
which means that 61% of the burden is borne by
children.
Lead
Human exposure to lead contributes mainly to cardio-
vascular diseases, mild mental retardation from child-
hood exposure leading to reduced intellectual function,
and additional outcomes which are more difficult to
quantify [30]. The 2004 global burden of disease for
these outcomes was estimated to be 143,000 deaths and
8,977,000 DALYs [14]. Among those, all deaths and
1,789,000 DALYs were due to lead-induced cardiovascu-
lar diseases in adults, and 7,189,000 DALYs were a
result of mild mental retardation due to lead-associated
IQ deficits, which means that children carried 80% of
the disease burden from lead. Childhood lead exposure
was estimated to contribute to about 600,000 new cases
of children with intellectual disabilities every year.
Between 2000 [31] and 2004, the proportion of the glo-
bal population with blood lead levels above 10 ug/dl
decreased from 20% to 14%, and resulted in similar
reductions in the disease burden, mainly due to impor-
tant efforts in phasing out leaded gasoline in most coun-
tries. It should be noted that blood lead levels can cause
disease well below 10 ug/dl. Other significant sources of
lead exposure however persist and continue to contri-
bute significantly to the overall disease burden [32,33].
Additional confirmed or suspected outcomes (see
Table 2) or health impacts from “hot spots” (e.g. locally
elevated exposures from industrial activities) were not
included in the estimate.
Arsenic in drinking-water
Human exposure to arsenic can cause a variety of health
effects and diseases, including cancer of the skin, blad-
der, kidney and lungs. Other effects of long-term expo-
sure are peripheral neuropathy, gastrointestinal
symptoms, diabetes, reproductive effects, enlarged liver,
bone marrow depression, destruction of erythrocytes,
high blood pressure and cardiovascular disease [34-36].
Exposure to arsenic can occur through different envir-
onmental pathways, including from mining and smelting
activities, burning of arsenic-rich coal and ingestion of
contaminated drinking-water. Arsenic mainly enters
drinking-water supplies through natural deposits in the
soil, but also through industrial and agricultural activ-
ities (including discharge of industrial wastes, burning of
fossil fuels - especially coal - and wastes, or use of pesti-
cides and food additives). The health impacts of expo-
sure to arsenic in drinking water have been estimated
for Bangladesh [11]. Another estimate has been per-
formed at global level, but is not comparable [37].
Arsenic-contaminated drinking-water in Bangladesh
alone contributed 9,100 deaths and 125,000 DALYs in
2001 from diabetes mellitus, ischaemic heart disease,
lung cancer, and bladder, kidney and skin cancer [11].
About two thirds of the total population exposed to ele-
vated drinking-water levels are estimated to reside in
Bangladesh [11]. The estimated burden of disease there-
fore represents a significant part of the global burden
from arsenic in drinking water. A global estimate, or an
estimate for other exposures than drinking water was
not available for arsenic.
Other health impact estimates available
Additional assessments of global health impacts of
selected chemicals have been made but results are not
comparable to the other analyses compiled here, either
because they were not expressed in DALYs and deaths,
or because DALYs have not been estimated in a com-
parable format. Examples include fluoride and mercury.
They are presented in the following paragraphs.
Fluoride
Insufficient fluoride intake increases the risk to develop
dental caries, while excessive intake can lead to dental
and skeletal fluorosis. High concentrations of fluoride
can enter public water systems from natural sources,
including runoff from the weathering of fluoride-con-
taining rocks and soils and leaching from soil into
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emissions can also contaminate water supplies [38].
Excessive fluoride concentrations in drinking water was
estimated to have caused about 47 million of dental
fluorosis cases and 20 million skeletal fluorosis cases in
17 countries (in terms of prevalence, based on point
estimates published between 1953 and 2000) [39].
Mercury
Mercury compounds are toxic to the nervous, digestive,
cardiovascular and immune systems, to the lungs, kid-
neys, skin, eyes, and gastrointestinal tract, and adversely
impact on development [40,41]. Mercury releases in the
environment result mainly from human activity, for
example emissions from coal-fired power plant, and the
use of mercury-containing products. Once in the envir-
onment, elemental mercury is naturally transformed
into methylmercury that bioaccumulates in fish and
shellfish. Human exposure occurs mainly through inha-
lation of elemental mercury vapors during industrial
processes and through consumption of contaminated
fish and shellfish. Transplacental exposure of the foetus
may also occur [42]. The analysis of disease burden
from methylmercury was limited to cognitive impacts
and mild mental retardation. It was estimated that,
among selected subsistence fishing populations, between
1.5/1000 and 17/1000 children showed cognitive impacts
caused by the consumption of fish containing methyl-
mercury. These results are however not comparable to
estimates of deaths and DALYs [41,43].
Results on data used in the burden of disease estimates
Exposures used in the burden of disease estimates have
included (a) international databases or systematic
reviews of monitoring/modelling of environmental
levels, such as for outdoor air pollution [44,45] and
arsenic [11,37] (b) international databases or systematic
reviews of survey data, such as for indoor air pollution
[46] and second-hand smoke [29] (c) systematic reviews
of bio-monitoring data, such as blood lead levels [31,47],
or (d) international databases or systematic reviews of
occupational exposures by sector or occupational cate-
gory, such as for occupational carcinogens [48] or occu-
pational particulates [15]. These exposure data have
been combined with exposure-risk information from
major reviews or epidemiological studies to result in
burden of disease estimates. Examples include lead and
hypertension or cardiovascular effects [49,50]; lead and
children’s intellectual function [51,52]; outdoor air pol-
lution and cardiopulmonary disease [53]; second-hand
smoke and related outcomes [27,28,54]; arsenic in drink-
ing-water and related outcomes [55]; occupational expo-
sure and lung cancer [56] or asbestos [57]). The
estimation of acute effects from chemicals at population
level has generally been based on the direct assessment
of cases or deaths, such as mortality statistics for unin-
tentional poisonings [58] and systematic reviews of vital
statistics, autopsy reports, surveillance systems, hospital-
based studies etc. for suicides involving pesticides [12].
Discussion
Estimated burden of disease from chemicals
This review shows that, based on estimations available
to date, the global burden of disease attributable to
environmental exposure and management of selected
chemicals amounts to at least 4.9 million deaths (86 mil-
lion DALYs) per year. This represents 8.3% of the total
deaths and 5.7% of the total burden of disease in
DALYs worldwide. For comparison, this is more than
the burden of all cancers worldwide, which account for
5.1% of all DALYs [58]. Fifty-four percent of this burden
(counted in DALYs) is borne by children under the age
of 15 years. The share of the total disease burden is con-
siderable, and supports the need for further public
health considerations in this area. By far the largest dis-
ease burden is related to exposure to air pollution mix-
tures with 70% of the total (Figure 2). Our estimate
includes available information for chemicals in a broad
sense, i.e. not only industrial and agricultural chemicals
but also air pollutants and some naturally occurring
chemicals. Available information for industrial and
agricultural chemicals and acute poisonings only (i.e.
without air pollution nor arsenic-contaminated drink-
ing-water) amounts to a global burden of disease of at
least 1.2 million deaths (25 million DALYs), correspond-
ing to 2.0% of the total deaths and 1.7% of the total
burden of disease worldwide.
Limitations
The global estimates presented in this article undoubt-
edly underestimate the real burden attributable to che-
micals. Comparing the identified disease burden from
chemicals with the health effects listed in Table 2 shows
that only limited relevant exposures and some of the
health impacts they cause have so far been quantified at
Air pollution mixtures
70%
Chemicals in 
occupational 
exposures 
(longer term effects)
8%
Single chemicals 
(longer term effects)
11%
Chemicals in acute 
poisonings
11%
Figure 2 Distribution of known burden of disease (in DALYs).
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underestimate: (a) Quantified exposure-response rela-
tionships, supported by strong evidence, between many
chemicals and their health outcomes are lacking. Estab-
lishing further links between certain chemicals and their
health hazards would be useful but may be complex;
(b) Large-scale exposure data are insufficient. Even che-
micals with health consequences supported by strong
evidence of causality therefore bear considerable knowl-
edge gaps in terms of population impact; (c) This analy-
sis also failed to capture much of the health impacts
from exposure to polluted sites which are estimated to
put at risk more than 56 million people worldwide [59];
such locally-specific health impacts are difficult to esti-
mate with available methods and should be considered
separately.
As this review is mostly built on previous estimates
developed by WHO - given the limited availability of
other estimates - the use of rigorous methods further
contributes to restricting the estimates to only those
supported by strong evidence and to ICD disease cate-
gories rather than including all health outcomes. Devel-
opment of additional estimates would contribute to
obtaining a fuller picture of the population health
impacts from chemicals.
This review is also limited in its scope: Not all chemi-
cals have been reviewed here, but only toxic exposures
to chemicals which can be significantly reduced or
eliminated through environmental and occupational
management as described in the background section.
Therefore lifestyle issues, such as active smoking or
other substance abuse, have not been taken into account
here. The same applies to chemicals acting on health
through radiation rather than their toxic properties.
Significant examples of chemicals with yet unknown
burden of disease include: a) chronic exposure to toxic
pesticides; b) exposure to mercury c) exposure to cad-
mium, d) exposure to additional occupational carcino-
gens. It is, unfortunately, not possible to conduct
estimates based on the different modes of action by
which chemicals exert their toxic effects, such as
through endocrine, immune or other systems.
While certain outcomes, such as those resulting from
acute poisonings or high-level exposures, may easily be
traced back to chemicals, other delayed or sub-clinical
health effects such as cancers or certain neurological
diseases are much more difficult to allocate to specific
exposures (Figure 3). This is particularly true for dis-
eases with long lag-times from exposures, complex
exposure assessment, and often non-specific health out-
comes. Also current toxicological test systems have lim-
itations in their ability to predict effects in humans.
Figure 2 schematically represents the possible fraction of
t h et r u eb u r d e no fd i s e a s ef r o mc h e m i c a le x p o s u r et h a t
has effectively been traced back with sufficient scientific
evidence to chemicals. It highlights that acute poison-
ings, outcomes caused by high-level exposures and rare
health effects in more controlled occupational environ-
ments are often easier to trace back to chemicals than
health effects resulting from the more frequent but
lower-level exposures.
Uncertainty estimates were rarely available for the
identified burden of disease estimates, and even if they
were, they mostly relied on expert opinion or variation of
selected input parameters rather than more systematic
assessments. This was due to difficulties in the evaluation
of the numerous uncertainties inherent to burden of dis-
ease estimates, which stem from exposure and exposure-
response relationships, their extrapolation from one
population to another or other parameter or model
uncertainties. Sources of uncertainties were different for
each of the assessed risk factors, and additional informa-
tion on their specific sources can be found in the original
publications (see references in Table 3).
The estimated disease burden does not show the
important beneficial effects of long-term regulation of
chemicals in food, consumer and other chemical pro-
ducts, industrial emissions and workers’ protection
which have already prevented a significant fraction of
the disease burden that would have occurred had these
controls not been in place. This is due to the fact that
the burden of disease estimates represent a “snapshot”
for about the year 2004, and limited information on
trends. For example, in 2003, the European Commission
forecast the health benefits of its REACH legislation to
be 50 billion Euros over 30 years [60].
To improve exposure information, bio-monitoring
initiatives are developing, and should continue improv-
ing large-scale exposure information [61,62]. New strate-
gies and initiatives have been implemented which might
change the picture of chemical exposure and risk assess-
ment and could improve estimation of disease burden
caused by chemicals (e.g. the REACH programme [60],
the High Throughput Screening Initiative [63]). In addi-
tion, alternative, innovative methods may be required to
estimate the full health impacts involving chemicals at
population level, using for example a combination of
disease trends, exposure patterns, biomarkers, and an
improved understanding of the human relevance of
effects seen in chemical testing systems.
Link to policy initiatives
In 2002 at the World Summit on Sustainable Develop-
ment (WSSD), governments renewed their commitment
to the sound management of chemicals throughout their
life cycle and of hazardous wastes. Governments aim to
assure, by 2020, that chemicals are used and produced
in ways that lead to the minimization of significant
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using transparent science-based risk assessment proce-
dures and science-based risk management procedures.
The burden of disease information presented here
shows that this goal has not been reached, and the lim-
ited available trend information indicates that renewed
efforts will be required over the next decade to 2020.
This is despite the knowledge that has long existed
about the adverse health impacts of lead, mercury,
asbestos and the other chemicals considered in this
paper.
While the estimation of the burden of disease attribu-
table to air pollution and naturally occurring chemicals
has involved exposure and risks assessments by health
or environment authorities, managing these exposures
and reducing risk often requires action by other sectors
and stakeholders, including regulatory bodies, industry
and civil society. These actors are often different than
those responsible for the sound management of agricul-
tural and industrial chemicals. For example, health
impacts and exposure to air pollution can primarily be
modified through action in the energy and transport
sectors and the industry, while arsenic in drinking-water
is managed through the water sector. Other exposures
involve chemicals only as a side-product of energy gen-
eration or of tobacco consumption, such as the main
contributions to outdoor and indoor air pollution. Redu-
cing human exposure to air pollutants and naturally
occurring chemicals therefore requires efforts from a
wide range of stakeholders, including industry and civil
society.
Our review indicates that public health can be
improved substantially, and in some cases relatively
quickly, by identifying and implementing further effec-
tive interventions on chemicals of major public health
concern including those addressed in this article. It is
particularly urgent to address those chemical such lead
and asbestos for which evidence, exposure and policy
options have been known for quite some time, interna-
tional agreements are in place, but exposure and effects
Acute 
poisonings
Diseases
caused by high-
level chronic 
exposures at work 
Diseases in the general population 
caused by lower level chronic exposures
Less frequent
outcomes
Adverse health effects
(developmental effects, organ function impairment)
Physiological changes of uncertain significance, body burden
More frequent
outcomes
Manifest 
health effects
Health effects only 
observable in 
specific surveys or 
investigations
Fraction of disease outcomes 
traced back to chemicals
Figure 3 Occurrence and detection of health impacts from chemicals Adapted from [64,65].
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governments can improve public health by collecting
information to identify the additional hazardous chemi-
cals to which their populations are exposed in order to
take action on the most important problems. Finally,
research aiming to improve our understanding of the
link between chemicals and negative health impacts is
imperative in order to prioritize actions and assess their
effectiveness.
Conclusions
This review shows that the currently known disease bur-
den from chemicals is large, and that the yet unknown
burden may be considerable. Although underestimated,
the global burden of disease attributable to chemicals is
useful information for international, regional and
national decision-makers from the different sectors and
programmes who have a role to play in reducing human
exposure to toxic chemicals (Figure 1). This review sup-
ports that further attention should focus on investigating
population health impacts from chemicals, and on the
preventive measures limiting harmful exposures to
chemicals.
The estimated burden of disease from chemicals and
its preventable fraction provides an indication of how
much disease burden could be prevented through tar-
geted action, and will facilitate the evaluation and moni-
toring of these actions in the future. For example the
proportion of people with blood lead levels above
10 ug/dl globally decreased from 20% to 14%, alongside
similar reductions in the disease burden it caused. This
reduction is due mostly to the phase out of leaded gaso-
line in most countries, providing a powerful example of
the impact risk management can have in a relatively
short time.
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